Widening Korea's telemedicine drug delivery now needs a second bill after December

The eligibility list is written by patient status. Under the revised bill, home delivery after a telemedicine consultation goes to residents of islands and remote areas, long-term care beneficiaries, people with disabilities, and patients with infectious or rare diseases ^[3]. A platform's delivery volume in December is whatever share of its consultations falls inside those categories. Sedaily's report does not include patient counts for them. The government wants the list widened to every telemedicine patient ^[1].

Widening it takes another bill. The Ministry of Health and Welfare, which leads the policy and is cautious about a full expansion ^[15], says extending delivery to all telemedicine patients would require further legal revision, and that carrying out a full expansion at the same time the system takes effect in December is difficult ^[9]. That puts two legislative steps between now and delivery for all telemedicine patients: December on the short list, and a later revision for anything past it ^[16]. The reform is driven from elsewhere, by the Office for Government Policy Coordination and the Ministry of SMEs and Startups, whose tone differs from the Health Ministry's ^[8]. Inside both, there is concern the expansion discussion loses momentum altogether if the Health Ministry leans toward the pharmacists' opposition ^[10]. "The Health Ministry has not yet spoken publicly, but there is a strong chance it will soon begin pressing a position that takes the pharmacists' views into account," a senior government official said ^[11].

The pharmacists' association declined to join the consultative body the Office for Government Policy Coordination plans to convene with pharmacist groups and telemedicine brokerage firms ^[4][5]. Its case is that expansion would give preferential treatment to private platforms, could encourage misuse, overuse and doctor shopping, and could weigh on national health insurance finances ^[6]. On the 20th it filled Gwanghwamun with a crowd organizers put at about 10,000, of whom 7,000 were pharmacists and 3,000 pharmacy students ^[7]. Three in ten of the people counted were students ^[14].

The industry has already conceded the principle. The Telemedicine Industry Council said it "is not calling for drug delivery to be expanded unconditionally" and that it "agrees with the pharmacists' argument that sufficient safeguards must be put in place" ^[12]. It asked for discussions on medication counseling, identity verification, delivery tracking, quality control and accountability for accidents, and on spelling out who can receive drugs at home and under what conditions ^[13].

I would expect December to run on the four categories in the bill, because the ministry that would have to draft the wider version has said it needs a separate revision ^[9], and the group whose objections that ministry is expected to weigh has stayed outside the process built to absorb them ^[5][11]. Two other paths are live. The consultative body could produce the safeguard package the council has offered, and a revision could move with it attached ^[13]. Or the association could join late and trade its participation for tighter conditions on counseling and tracking ^[13]. Two things would prove the first reading wrong: the Health Ministry saying the eligibility categories can be changed without new legislation, or the association taking a seat.